hydrochlorothiazide has been researched along with Myocardial Infarction in 44 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the hypothesis that losartan improves outcome better than atenolol in patients with isolated systolic hypertension and electrocardiographically documented left ventricular hypertrophy (ECG-LVH)." | 9.10 | Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. ( Aurup, P; Beevers, G; Dahlöf, B; de Faire, U; Devereux, RB; Edelman, J; Fyhrquist, F; Ibsen, H; Julius, S; Kjeldsen, SE; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Snapinn, S; Wedel, H, 2002) |
| " We now studied renal effects of adding hydrochlorothiazide to ACE inhibitor after myocardial infarction in rats." | 7.75 | Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor. ( Buikema, H; Hamming, I; Navis, G; Schoemaker, RG; Szymanski, MK; van Gilst, WH; van Goor, H; Westendorp, B, 2009) |
| "The case of a 68 year old man in whom hydrochlorothiazide induced pulmonary oedema with hypovolaemic shock is presented." | 7.68 | Pulmonary oedema with shock induced by hydrochlorothiazide: a rare side effect mimicking myocardial infarction. ( Høegholm, A; Kristensen, KS; Rasmussen, SW, 1990) |
| "Heart failure is a major cause of morbidity and mortality worldwide." | 5.37 | Effects of hydrochlorothiazide on cardiac remodeling in a rat model of myocardial infarction-induced congestive heart failure. ( Dai, G; Gao, X; Luo, J; Peng, L; Sun, H, 2011) |
| " The Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial showed that the combination of benazepril+amlodipine (B+A) is superior to benazepril+hydrochlorothiazide (B+H) in reducing CV events." | 5.20 | Amlodipine+benazepril is superior to hydrochlorothiazide+benazepril irrespective of baseline pulse pressure: subanalysis of the ACCOMPLISH trial. ( Asp, J; Dahlöf, B; Jamerson, KA; Jia, Y; Kjeldsen, SE; Östergren, J; Skoglund, PH; Svensson, P; Weber, MA; Zappe, DH, 2015) |
| "The primary objective of this study was to determine whether combination therapy with valsartan 160 mg plus hydrochlorothiazide (HCTZ) 25 mg OD would be more effective than monotherapy with amlodipine 10 mg OD in reducing systolic blood pressure (SBP) in patients with moderate (stage II) hypertension and > or =1 other cardiovascular risk factor or concomitant condition." | 5.11 | Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. ( Bönner, G; Heintz, D; Kandra, A; Khder, Y; Malacco, E; Ruilope, LM, 2005) |
| "To test the hypothesis that losartan improves outcome better than atenolol in patients with isolated systolic hypertension and electrocardiographically documented left ventricular hypertrophy (ECG-LVH)." | 5.10 | Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. ( Aurup, P; Beevers, G; Dahlöf, B; de Faire, U; Devereux, RB; Edelman, J; Fyhrquist, F; Ibsen, H; Julius, S; Kjeldsen, SE; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Snapinn, S; Wedel, H, 2002) |
| "There is significant controversy around whether chlorthalidone (CTD) is superior to hydrochlorothiazide (HCTZ) in hypertension management." | 3.77 | Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. ( Bleske, BE; Dorsch, MP; Erickson, SR; Gillespie, BW; Weder, AB, 2011) |
| " We now studied renal effects of adding hydrochlorothiazide to ACE inhibitor after myocardial infarction in rats." | 3.75 | Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor. ( Buikema, H; Hamming, I; Navis, G; Schoemaker, RG; Szymanski, MK; van Gilst, WH; van Goor, H; Westendorp, B, 2009) |
| " Of 10,991 myocardial infarction survivors dispensed atenolol, metoprolol, propranolol, or timolol, 9458 (86." | 3.70 | Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose. ( Anderson, GM; Clark, JP; Gurwitz, JH; Lau, P; Rochon, PA; Shear, NH; Tu, JV, 1999) |
| "The case of a 68 year old man in whom hydrochlorothiazide induced pulmonary oedema with hypovolaemic shock is presented." | 3.68 | Pulmonary oedema with shock induced by hydrochlorothiazide: a rare side effect mimicking myocardial infarction. ( Høegholm, A; Kristensen, KS; Rasmussen, SW, 1990) |
| "The effect of potassium ion (K+) depletion on postmyocardial infarction ventricular arrhythmias was investigated in 32 dogs: 12 control animals, 10 animals that ate a diet extremely low in K+ for 15 days, and 10 others that, in addition to dietary K+ deprivation, received 50 mg of hydrochlorothiazide four times." | 3.67 | The effect of potassium ion depletion on postinfarction canine cardiac arrhythmias. ( Bodvarsson, M; Canzanello, VJ; Garan, H; Harrington, JT; Madias, NE; McCauley, J; McGovern, BA; Newell, JB; Ruskin, JN, 1988) |
| "Acute myocardial infarction was not proven (later coronarography revealed preserved coronary circulation), but severe hyponatraemia and hypokalaemia was detected, explaining a possible symptomatic seizure, and which could be accounted for a 25 mg daily hydrochlorothiazide antihypertensive treatment and - as a precipitating insult - a one-week history of gastroenteritis." | 1.46 | [Differential diagnostic dilemmas after use of an out-of-date antihypertensive medication. Case report]. ( Arányi, P; Tomcsányi, J, 2017) |
| "Heart failure is a major cause of morbidity and mortality worldwide." | 1.37 | Effects of hydrochlorothiazide on cardiac remodeling in a rat model of myocardial infarction-induced congestive heart failure. ( Dai, G; Gao, X; Luo, J; Peng, L; Sun, H, 2011) |
| "Acute myocardial infarction is a rare complication of mitral stenosis." | 1.33 | Acute myocardial infarction in a patient with severe unrecognized mitral stenosis. ( Bajraktari, G; Beqiri, A; Berisha, I; Elezi, S; Kastrati, S; Manaj, R; Thaqi, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (52.27) | 18.7374 |
| 1990's | 5 (11.36) | 18.2507 |
| 2000's | 8 (18.18) | 29.6817 |
| 2010's | 8 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skoglund, PH | 1 |
| Svensson, P | 1 |
| Asp, J | 1 |
| Dahlöf, B | 3 |
| Kjeldsen, SE | 3 |
| Jamerson, KA | 1 |
| Weber, MA | 4 |
| Jia, Y | 2 |
| Zappe, DH | 2 |
| Östergren, J | 1 |
| Wald, NJ | 2 |
| Luteijn, JM | 2 |
| Morris, JK | 2 |
| Taylor, D | 1 |
| Oppenheimer, P | 1 |
| Arányi, P | 1 |
| Tomcsányi, J | 1 |
| Westendorp, B | 3 |
| Hamming, I | 1 |
| Szymanski, MK | 1 |
| Navis, G | 1 |
| van Goor, H | 1 |
| Buikema, H | 3 |
| van Gilst, WH | 3 |
| Schoemaker, RG | 3 |
| Dorsch, MP | 1 |
| Gillespie, BW | 1 |
| Erickson, SR | 1 |
| Bleske, BE | 1 |
| Weder, AB | 1 |
| Luo, J | 1 |
| Gao, X | 1 |
| Peng, L | 1 |
| Sun, H | 1 |
| Dai, G | 1 |
| Julius, S | 2 |
| Brunner, HR | 1 |
| Hua, TA | 1 |
| McInnes, GT | 1 |
| Schork, A | 1 |
| Mancia, G | 1 |
| Zanchetti, A | 3 |
| Devereux, RB | 1 |
| Aurup, P | 1 |
| Edelman, J | 1 |
| Beevers, G | 1 |
| de Faire, U | 1 |
| Fyhrquist, F | 1 |
| Ibsen, H | 1 |
| Kristianson, K | 1 |
| Lederballe-Pedersen, O | 1 |
| Lindholm, LH | 1 |
| Nieminen, MS | 1 |
| Omvik, P | 1 |
| Oparil, S | 1 |
| Snapinn, S | 1 |
| Wedel, H | 1 |
| Staessen, JA | 1 |
| Thijisq, L | 1 |
| Fagard, R | 1 |
| Celis, H | 1 |
| Birkenhäger, WH | 1 |
| Bulpitt, CJ | 1 |
| de Leeuw, PW | 1 |
| Fletcher, AE | 1 |
| Forette, F | 1 |
| Leonetti, G | 1 |
| McCormack, P | 1 |
| Nachev, C | 1 |
| O'Brien, E | 1 |
| Rodicio, JL | 1 |
| Rosenfeld, J | 1 |
| Sarti, C | 1 |
| Tuomilehto, J | 1 |
| Webster, J | 1 |
| Yodfat, Y | 1 |
| Ruilope, LM | 1 |
| Malacco, E | 1 |
| Khder, Y | 1 |
| Kandra, A | 1 |
| Bönner, G | 1 |
| Heintz, D | 1 |
| van Veldhuisen, DJ | 2 |
| de Zeeuw, D | 1 |
| Boomsma, F | 1 |
| Bajraktari, G | 1 |
| Kastrati, S | 1 |
| Manaj, R | 1 |
| Berisha, I | 1 |
| Thaqi, S | 1 |
| Beqiri, A | 1 |
| Elezi, S | 1 |
| Bakris, GL | 1 |
| Pitt, B | 1 |
| Velazquez, E | 1 |
| Gupte, J | 1 |
| Lefkowitz, M | 1 |
| Hester, A | 1 |
| Shi, V | 1 |
| Weir, M | 1 |
| Kjeldsen, S | 1 |
| Massie, B | 1 |
| Nesbitt, S | 1 |
| Ofili, E | 1 |
| Jamerson, K | 1 |
| Brugger, P | 1 |
| Klein, G | 1 |
| Perry, HM | 1 |
| Ferguson, RK | 1 |
| Vlasses, PH | 1 |
| Koplin, JR | 1 |
| Shirinian, A | 1 |
| Burke, JF | 1 |
| Alexander, JC | 1 |
| Freis, E | 1 |
| Angelkort, B | 1 |
| Letzel, H | 1 |
| Opasich, C | 1 |
| Cobelli, F | 1 |
| Assandri, J | 1 |
| Vecchio, C | 1 |
| Nordrehaug, JE | 1 |
| Vollset, SE | 1 |
| Leser, C | 1 |
| Bolliger, CT | 1 |
| Winnewisser, J | 1 |
| Burkart, F | 1 |
| Perruchoud, AP | 1 |
| Black, HR | 1 |
| Elliott, WJ | 1 |
| Neaton, JD | 1 |
| Grandits, G | 1 |
| Grambsch, P | 1 |
| Grimm, RH | 1 |
| Hansson, L | 1 |
| Lacoucière, Y | 1 |
| Muller, J | 1 |
| Sleight, P | 1 |
| White, WB | 1 |
| Williams, G | 1 |
| Wittes, J | 1 |
| Fakouhi, TD | 1 |
| Rochon, PA | 1 |
| Anderson, GM | 1 |
| Tu, JV | 1 |
| Gurwitz, JH | 1 |
| Clark, JP | 1 |
| Shear, NH | 1 |
| Lau, P | 1 |
| Ames, RP | 1 |
| Hill, P | 1 |
| Spotnitz, HM | 1 |
| Diethelm, AG | 1 |
| Hartley, MW | 1 |
| Aldrete, JS | 1 |
| Sterling, WA | 1 |
| Morgan, JM | 1 |
| Taguchi, J | 1 |
| Freis, ED | 3 |
| Høegholm, A | 1 |
| Rasmussen, SW | 1 |
| Kristensen, KS | 1 |
| Kuller, LH | 1 |
| Hulley, SB | 1 |
| Cohen, JD | 1 |
| Neaton, J | 1 |
| Garan, H | 1 |
| McGovern, BA | 1 |
| Canzanello, VJ | 1 |
| McCauley, J | 1 |
| Bodvarsson, M | 1 |
| Harrington, JT | 1 |
| Madias, NE | 1 |
| Newell, JB | 1 |
| Ruskin, JN | 1 |
| Alderman, MH | 1 |
| Ooi, WL | 1 |
| Madhavan, S | 1 |
| Cohen, H | 1 |
| Kaplan, NM | 1 |
| Abraham, AS | 1 |
| Rosenman, D | 1 |
| Meshulam, Z | 1 |
| Balkin, J | 1 |
| Zion, M | 1 |
| Eylath, U | 1 |
| Sweet, RL | 1 |
| Sheffield, LT | 1 |
| Doshchitsin, VL | 1 |
| Gratsianskii, NA | 1 |
| Eremina, GA | 1 |
| Chasis, H | 1 |
| Selye, H | 1 |
| Somogyi, A | 1 |
| Savoie, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study of Cardiac Magnetic Resonance in Patients With Muscular Dystrophy[NCT02921321] | 100 participants (Anticipated) | Observational | 2014-01-31 | Active, not recruiting | |||
| A Triple-Blind, Parallel Study to Investigate the Effect of Losartan Versus Atenolol on the Reduction of Morbidity and Mortality in Hypertensive Patients With Left Ventricular Hypertrophy[NCT00338260] | Phase 3 | 496 participants (Actual) | Interventional | 1995-06-30 | Completed | ||
| Stroke Prediction Study Using a Model Based on Internet Search Queries[NCT04755959] | 450 participants (Anticipated) | Observational | 2021-02-28 | Not yet recruiting | |||
| [NCT00000487] | Phase 3 | 0 participants | Interventional | 1972-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for hydrochlorothiazide and Myocardial Infarction
| Article | Year |
|---|---|
[Exertion hypertension in coronary disease and its importance in prevention and rehabilitation].
Topics: Adult; Coronary Disease; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Middle | 1982 |
Elderly hypertensive patient. Epidemiologic review.
Topics: Adult; Age Factors; Aged; Cerebrovascular Disorders; Female; Humans; Hydrochlorothiazide; Hypertensi | 1978 |
Effectiveness of drug therapy in hypertension: present status. A review.
Topics: Antihypertensive Agents; Cerebrovascular Disorders; Coronary Disease; Eye Diseases; Ganglionic Block | 1971 |
13 trials available for hydrochlorothiazide and Myocardial Infarction
| Article | Year |
|---|---|
Amlodipine+benazepril is superior to hydrochlorothiazide+benazepril irrespective of baseline pulse pressure: subanalysis of the ACCOMPLISH trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Double-Blind Method; Drug T | 2015 |
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Double-Blind Met | 2012 |
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
Topics: Aged; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Double-Blind Method; Female; Human | 2002 |
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
Topics: Aged; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Double-Blind Method; Female; Human | 2002 |
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
Topics: Aged; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Double-Blind Method; Female; Human | 2002 |
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
Topics: Aged; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Double-Blind Method; Female; Human | 2002 |
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus; Dihydrop | 2004 |
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Topics: Age Factors; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; D | 2005 |
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Body Mass Index; Diabetes Mellitus, Type 2; | 2007 |
[Current state of the treatment of arterial hypertension].
Topics: Adult; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Heart Failure; Humans; Hydralazine | 1980 |
[Clinical aspects and therapy of hydropic heart insufficiency. Results of a multicenter field study].
Topics: Adult; Aged; Clinical Trials as Topic; Coronary Disease; Drug Therapy, Combination; Edema, Cardiac; | 1981 |
Reduction of exercise-induced ventricular arrhythmias in mild symptomatic heart failure by benazepril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiac Complexes, Premature; Double-Blind M | 1993 |
Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.
Topics: Aged; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Cerebrovascular Disorders; Double- | 1998 |
Partial versus complete control of blood pressure in the prevention of hypertensive complications.
Topics: Atrial Fibrillation; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Follow-Up St | 1975 |
Intracellular cations and diuretic therapy following acute myocardial infarction.
Topics: Amiloride; Calcium; Cations; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Erythro | 1986 |
Appraisal of antihypertensive drug therapy.
Topics: Antihypertensive Agents; Arteriosclerosis; Clinical Trials as Topic; Coronary Disease; Diabetes Comp | 1974 |
28 other studies available for hydrochlorothiazide and Myocardial Infarction
| Article | Year |
|---|---|
Cost-benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke.
Topics: Aged; Aged, 80 and over; Amlodipine; Aspirin; Cardiovascular Agents; Case-Control Studies; Cohort St | 2016 |
Starting the polypill: the use of a single age cut-off in males and females.
Topics: Adult; Age Factors; Aged; Cardiovascular Agents; Drug Combinations; Female; Humans; Hydrochlorothiaz | 2017 |
[Differential diagnostic dilemmas after use of an out-of-date antihypertensive medication. Case report].
Topics: Antihypertensive Agents; Diagnosis, Differential; Female; Humans; Hydrochlorothiazide; Hypokalemia; | 2017 |
Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Diuretics; Heart; Hydrochlorothiazide | 2009 |
Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis.
Topics: Adult; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Cholesterol; Heart | 2011 |
Effects of hydrochlorothiazide on cardiac remodeling in a rat model of myocardial infarction-induced congestive heart failure.
Topics: Animals; Collagen; Cytokines; Disease Models, Animal; Electrolytes; Gene Expression Regulation; Hear | 2011 |
[Antihypertensive therapy in routine practice: fixed or free combination? Fixed combination scores with better prognosis].
Topics: Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Drug Combinations; Huma | 2011 |
Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Creatinine; Drug Therapy, Combination; | 2005 |
Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Drug Therapy, Combination | 2005 |
Acute myocardial infarction in a patient with severe unrecognized mitral stenosis.
Topics: Analgesics; Anti-Arrhythmia Agents; Anticholesteremic Agents; Anticoagulants; Aspirin; Atrial Fibril | 2006 |
Some wrong-way chemical changes during antihypertensive treatment: comparison of indapamide and related agents.
Topics: Adult; Antihypertensive Agents; Chemical Phenomena; Chemistry; Chlorthalidone; Diuretics; Humans; Hy | 1983 |
Captopril in severe treatment-resistant hypertension.
Topics: Adolescent; Adult; Aged; Blood Pressure; Captopril; Female; Furosemide; Heart Rate; Humans; Hydralaz | 1980 |
[The syndrome of hypertension of effort in the rehabilitation of patients with recent myocardial infarct. Problems of drug therapy].
Topics: Amiloride; Antihypertensive Agents; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hyperten | 1980 |
Pulmonary oedema and hypotension induced by hydrochlorothiazide.
Topics: Anaphylaxis; Diagnosis, Differential; Dyspnea; Female; Humans; Hydrochlorothiazide; Hypotension; Mid | 1994 |
Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Atenolol; Chlorthalidone; Confide | 1999 |
Raised serum lipid concentrations during diuretic treatment of hypertension: a study of predictive indexes.
Topics: Adult; Cholesterol; Diuretics; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; | 1978 |
Treatment of accelerated hypertension and end stage renal failure by bilateral nephrectomy and renal transplantation.
Topics: Acute Kidney Injury; Adult; Biopsy; Blood Pressure; Child; Creatinine; Female; Graft Rejection; Guan | 1975 |
Pulmonary oedema with shock induced by hydrochlorothiazide: a rare side effect mimicking myocardial infarction.
Topics: Aged; Diagnosis, Differential; Echocardiography; Humans; Hydrochlorothiazide; Male; Myocardial Infar | 1990 |
Unexpected effects of treating hypertension in men with electrocardiographic abnormalities: a critical analysis.
Topics: Adult; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomegaly; Catecholamines; Chlorthalid | 1986 |
The effect of potassium ion depletion on postinfarction canine cardiac arrhythmias.
Topics: Animals; Dogs; Electrophysiology; Female; Hydrochlorothiazide; Ion Channels; Myocardial Infarction; | 1988 |
Treatment-induced blood pressure reduction and the risk of myocardial infarction.
Topics: Blood Pressure; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle A | 1989 |
Problems with the use of diuretics in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Coronary Disease; Diuretics; Female; Humans; Hydrochlor | 1986 |
Results of treatment of hypertension.
Topics: Acute Kidney Injury; Antihypertensive Agents; Cardiovascular Diseases; Coronary Disease; Female; Hum | 1971 |
When a drug is the culprit.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Clofibrate; Depression; Drug-Related Side Effect | 1973 |
Myocardial infarction after exercise-induced electrocardiographic changes in a patient with variant angina pectoris.
Topics: Amitriptyline; Angina Pectoris; Arteriosclerosis; Catheterization; Diabetes Complications; Electroca | 1974 |
[Atrioventricular blockade and its treatment in acute myocardial infarct].
Topics: Acute Disease; Administration, Oral; Aged; Atropine; Electric Stimulation Therapy; Electrocardiograp | 1973 |
Hypertension: challenge in preventive medicine.
Topics: Aged; Aneurysm; Cardiovascular Diseases; Cerebral Hemorrhage; Cerebrovascular Disorders; Drug Therap | 1973 |
Prevention of stress-induced cardiac necrosis by amiloride.
Topics: Animals; Diuretics; Ethacrynic Acid; Female; Heart Diseases; Hydrochlorothiazide; Immobilization; My | 1969 |